Shifting from static to dynamic: the prognostic value of the surgical stress response in hepatocellular carcinoma Authors: Takatsugu Matsumoto, Hiroki Sato, Maiko Niki, Tomoaki Hayakawa, Genki Tanaka, Takayuki Shimizu, Takayuki Shiraki, Shozo Mori, Taku Aoki Published: 2026 Hepatocellular carcinoma (HCC) remains a formidable global health challenge. While radical resection offers the most promising treatment for a cure, the persistently high rates of postoperative recurrence highlight the critical need for precise, individualized prognostic biomarkers. In recent years, the interplay between the host immune-inflammatory system and tumor biology has taken center stage in oncology. Integrated staging models and nomograms have proven increasingly superior to traditional staging by incorporating systemic factors to accurately predict individual survival (1). Specifically, the systemic immune-inflammation index (SII), integrating platelet, neutrophil, and lymphocyte counts, has been widely recognized as a robust prognostic indicator in these comprehensive models (2). However, traditional markers like the baseline SII are inherently static. This static approach overlooks a profound physiological event: the surgical intervention itself. In the recent issue of the Journal of Gastrointestinal Oncology, Zou and colleagues present a compelling study that challenges this static paradigm (3). They introduce a novel metric, the postoperative-to-preoperative SII ratio (ΔSII), to capture the dynamic magnitude of the surgical stress response. In their retrospective analysis of 244 patients undergoing curative-intent resection for HCC, the authors demonstrated that a high ΔSII (>6.839) on postoperative day 1 (POD1) is a powerful, independent predictor of poor overall survival (OS) and recurrence-free survival (RFS). Strikingly, the prognostic accuracy of the ΔSII significantly outperformed the conventional preoperative SII. The physiological implications of this elevated ΔSII are particularly intriguing. Surgical trauma is not merely a mechanical event; it triggers a cascade of systemic inflammation and concurrent immunosuppression (4). The dramatic surge in SII observed in the high-ΔSII group reflects a dysregulated, maladaptive immune response. This early postoperative window, characterized by profound neutrophilia and lymphopenia, creates a favorable environment for circulating tumor cells to evade immune surveillance and establish micrometastases. By capturing this specific window, the ΔSII serves as a quantifiable surrogate for a patient’s vulnerability to surgically induced oncological progression. From a surgical perspective, the study addresses a critical viewpoint: the relationship between the extent of surgical trauma and the inflammatory response. The authors found that a high ΔSII was strongly associated with more extensive procedures, including major hepatectomy and open surgical approaches. However, their stratified survival analysis revealed a profound insight: patients with a low ΔSII who underwent open surgery exhibited vastly superior survival compared to those with a high ΔSII undergoing laparoscopic surgery. Recent high-impact studies utilizing preoperative nomograms have repeatedly highlighted that physiological reserve and the anticipated surgical stress are as critical as tumor burden in determining survival (5-7). The ΔSII corroborates this, indicating that while surgical trauma influences the inflammatory response, it is the patient’s inherent, maladaptive inflammatory phenotype that ultimately dictates the oncological outcome. Looking forward, the comparative analysis of ΔSII across different surgical modalities—namely open, conventional laparoscopic, and robotic-assisted surgery—emerges as a highly compelling future perspective. As robotic surgery continues to gain attention in hepato-biliary-pancreatic surgery, offering unprecedented precision and potentially minimizing tissue trauma even further than conventional laparoscopy, ΔSII could serve as an objective, quantitative benchmark for evaluating surgical invasiveness. Integrated predictive models are increasingly being used to guide treatment allocation for HCC (8). By systematically tracking dynamic indices like ΔSII, we can better deduce how the subtle differences in surgical trauma among these modalities translate into long-term oncological prognoses, thereby refining these integrated models to guide the optimal selection of surgical approaches for individual patients. Beyond refining surgical techniques, the identification of a high-ΔSII cohort highlights a critical clinical challenge: developing effective interventions to actively improve the prognosis of these high-risk patients. Because a high ΔSII reflects a state of acute postoperative immunosuppression and dysregulated inflammation, this specific group may be the ideal target for adjuvant therapies aimed at bolstering anti-tumor immunity. In this context, the perioperative application of immune checkpoint inhibitors (ICIs) could represent a potential therapeutic option (9). Active investigation into how ICIs might counteract surgically induced immunological exhaustion will be essential. This approach could be the key to preventing early recurrence, effectively translating the ΔSII from a purely prognostic biomarker into a guide for targeted therapeutic intervention. While the integration of the ΔSII into a nomogram provides a highly practical clinical tool, the study is not without limitations. The cohort is predominantly composed of hepatitis B virus (HBV)-related HCC patients from a single institution. External validation across diverse etiologies is a mandatory next step. Furthermore, measuring the inflammatory response solely on POD1, while practical, may not fully encapsulate the dynamic resolution of inflammation. Future prospective studies tracking serial perioperative indices will be essential to identify the most prognostic temporal window. In conclusion, Zou et al. have made a highly valuable contribution by shifting the focus from static baseline characteristics to the dynamic physiological realities of the perioperative period. The ΔSII concept bridges the gap between surgical technique, postoperative immunology, and tumor biology. Through the continued refinement of minimally invasive surgical skills and targeted perioperative immunomodulation, we may soon be able to blunt the ΔSII spike, transforming a period of extreme physiological vulnerability into an opportunity for improved oncological control. Supplementary The article’s supplementary files as